Skip to content

In the BioHarmony Drug Report Database


Mestinon, Pyridostigmine Bromide, Regonol (pyridostigmine) is a small molecule pharmaceutical. Pyridostigmine was first approved as Mestinon on 1982-01-01. It is used to treat drug-induced abnormalities and myasthenia gravis in the USA. It is known to target acetylcholinesterase and cholinesterase.
Trade Name Mestinon, Pyridostigmine Bromide, Regonol
Common Name Pyridostigmine
Indication drug-induced abnormalities, myasthenia gravis
Drug Class Cholinesterase inhibitors (physostigmine type)
Get full access now